UNSPSC 85252854: Diagnosis of acute erythroid leukaemia

This classification denotes the group of activities that yields a diagnosis of Acute erythroid leukaemia. Acute erythroid leukaemia is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C94. 0

UNSPSC 85252854 Diagnosis of acute erythroid leukaemia is a Commodity code that shows little relevant recent activity under its nominal clinical scope. The three recent state and local opportunities posted under this code do not align with acute erythemoid leukaemia diagnosis. Instead, they span diagnostic imaging systems (San Mateo Medical Center's PACS procurement), special education contracted services (Birdville Independent School District), and temporary health professional staffing across ancillary clinical categories (Santa Clara County Health System). The mismatch between the code's stated purpose and the actual work being tagged suggests the code is either misapplied in state and local procurement systems or is being used as a catch-all for health services purchases that do not fit established taxonomy.

Recent opportunities originate from California county health systems (San Mateo, Santa Clara) and a Texas school district, with no geographic concentration apparent from this limited sample. The San Mateo Medical Center RFP, posted October 7, 2026 with proposals due October 21, 2026, seeks an enterprise-grade PACS implementation with EPIC integration to support approximately 65,000 radiology studies, 5,000 cardiology studies, and 8,000 mammography interpretations annually, with implementation required within 9–12 months. Santa Clara County Health System's RFQ, posted July 7, 2026 with proposals due October 7, 2026, establishes a multiple-award qualified vendor pool for temporary health professional staffing across 13 ancillary categories including diagnostic imaging and radiology, cardiology, audiology, and therapy services, with no guaranteed work volume. Neither opportunity directly addresses leukaemia diagnosis services. The code's current activity does not support reliable market characterization for acute erythroid leukaemia diagnosis procurement.